2007 TransMed Forum Proceedings 
A great challenge facing modern medicine today is the clash between the
short-term, earnings-driven requirements of the medical marketplace and
the risky, long, and capital-intensive process of bringing medical
ideas to fruition.
2010 Translational Medicine Alliance Forum Announced
The Translational Medicine Alliance Forum will convene October 13–14, 2010 at the Mandarin Oriental in Washington, DC. This year’s Forum will be hosted by three organizations with the common interest of accelerating translational research to the patient.
A Cure for the Drug Discovery Gap
Frank Douglas, a senior fellow at the Kauffman
Foundation, explores one idea
for catalyzing medical research to help bridge the gap between the laboratory
discovery and treatment option.
Assessing Risk and Return: Personalized Medicine Development & New Innovation Paradigm
As the biopharmaceutical industry faces declining productivity and
innovation, personalized medicine—the concept that a person’s genetic
makeup could be used to tailor medical care to that individual’s
needs—offers promise for increasing economic returns, according to
“Assessing Risk and Return: Personalized Medicine Development & New
Innovation Paradigm.”
Building Interest in Entrepreneurship and Innovation Among European Foundations
Karen Wilson, Kauffman Senior Fellow, interviews individuals at three leading foundations in
Europe that have been active in promoting entrepreneurship.
Call for Applications: Kauffman Life Science Ventures Summit
Life science startups face more complex and daunting hurdles than new enterprises in non-regulated industries do. To help aspiring and early-stage life science entrepreneurs address these challenges, the Ewing Marion Kauffman Foundation will hold a Kauffman Life Science Ventures Summit June 22-23, 2012.
Entrepreneur Postdoctoral Fellows Program
With the aim of cultivating entrepreneurs from among the postdoctoral community, the Kauffman Foundation’s Entrepreneur Postdoctoral Fellows program educates and trains scientist-founders who will create the high-growth technology companies of tomorrow.
Expanded Private Sector Comparative Effective Research Could Reduce Health Care Spending, According to Kauffman Study
Policies that incentivize the private sector to invest in comparative effective research (CER) could reduce the growth rate in U.S. health care spending—while improving the overall quality of care. That's according to a new Kauffman Foundation-funded study by Wharton School professor Scott Harrington.
Gender Differences in Patenting in the Academic Life Sciences
Male academic scientists in the life sciences secure patents at more than twice the rate of their female colleagues, according to the study Gender Differences in Patenting in the Academic Life Scientists.
HHS Secretary Sebelius Joins Health Care Leaders at Kauffman Foundation to Discuss New Roles in Drug Discovery and Development
Academic institutions across the United States are playing a critical role in developing life-saving treatments, procedures and innovations, and must be supported by a public policy agenda designed to foster continued growth and investment, U.S. Secretary of Health and Human Services Kathleen Sebelius told a gathering of leaders from the public and private sectors here today.
Huffington Post Op-Ed Highlights Translational Medicine Alliance
Kauffman Foundation vice president of advancing innovation Lesa Mitchell posted an opinion piece on the Huffington Post about a group of scientists, researchers, and philanthropists who have been working to bridge the gap between basic research and patient care. Mitchell's essay stresses the importance of advancing the movement of scientific breakthroughs in the lab to the market, and thus, to the patient.
Incentivizing Comparative Effectiveness Research
Comparative effective research (CER) compares alternative methods of preventing, diagnosing, treating, and otherwise managing medical conditions.
Innovation is Rapidly Globalizing: India and China are Becoming Centers of Pharmaceutical R&D says Kauffman Foundation Study
Cost pressures, the need to tap global talent, and growth opportunities in emerging markets led Western pharmaceutical companies to shift substantial manufacturing and clinical-trial work to China and India. But a new study sponsored by the Ewing Marion Kauffman Foundation on the globalization of the pharmaceutical industry shows that big pharmaceutical companies such as Merck, Eli Lilly and Johnson & Johnson are now counting on these countries for advanced research and development as well.
Institute for Advancing Medical Innovation
Getting new treatments and cures to patients more quickly is the goal
of a unique life science proof-of-concept model that draws support from
higher education, philanthropy and industry experts to move medical
innovations from the lab to the market.
Institute for Pediatric Innovation, Newly Formed Nonprofit, Announces Consortium of Leading Children's Hospitals to Focus on Developing Products Optimized for Children's Healthcare
The Institute for Pediatric Innovation (IPI), Inc., a recently formed nonprofit focused on improving healthcare for children, today announced the formation of a Consortium of Pediatric Hospitals - a group of nationally recognized children's hospitals that will collaborate with the Institute in its mission.
Intel's Andy Grove and Safeway's Steve Burd Headline Global Technology Leaders Conference on Cost-effective Health Care
Can technological innovation rein in our nation's escalating health
care costs? On Wednesday, Nov. 18, luminaries including Andy Grove,
former CEO of Intel, and Steve Burd, CEO of Safeway, will take up this
question at the second annual A. Richard Newton Global Technology
Leaders Conference, titled Translating Technology into Cost-Effective Health Care.
Join an Interactive Webinar on a New Model for Drug Development
The Myelin Repair Foundation, Ewing Marion Kauffman Foundation, Pioneer Portfolio of the Robert Wood Johnson Foundation, and the Scott Cook & Signe Ostby Foundation invite you to participate in an interactive webinar to discuss a new drug development model employed by the Myelin Repair Foundation with the potential to cut years from the drug development timeline, saving lives and money.
Jump-Starting Innovation in Medical Research
Michael Milken provides an overview of the Prostate
Cancer Foundation's work, showing us that it is possible to jump-start innovation in
medical research.
Kansas City Life Sciences Fund
The Kansas City Life Sciences Fund, which received an initial
contribution of $1.5 million from the Ewing Marion Kauffman Foundation,
will enable donors across the region to help Kansas City recruit top
medical research talent focusing especially on cures for cancer and
diabetes.
Kauffman Entrepreneur Postdoctoral Fellows' Inaugural Class Embarks on Intensive Training Program
The Ewing Marion Kauffman Foundation today welcomed its inaugural class
of Entrepreneur Postdoctoral Fellows for its fall program workshop, the
first in a series of workshops planned over the next year. As part of
the new Kauffman Labs for Enterprise Creation initiative, the Fellows
program will tap the entrepreneurial potential of 13 brilliant
postdoctoral researchers.
Kauffman Foundation Launches Entrepreneur Fellows Program to Increase Number of High-Growth Startup Founders
The Ewing Marion Kauffman Foundation announced today a new fellowship
program that will increase the number of experienced founders for
startup companies and help the Foundation better understand the
dynamics of firm formation, or what the Foundation calls the "science
of startups."
Kauffman Foundation Seeds Kansas City Life Sciences Fund
The establishment of the Kansas City Life Sciences Fund, which has
received an initial contribution of $1.5 million from the Ewing Marion
Kauffman Foundation, will enable donors across the region to help
Kansas City recruit top medical research talent focusing especially on
cures for cancer and diabetes.
Kauffman Foundation Sponsors Personalized Health Project’s 'Take Action' Summit: A Call for Transforming Healthcare
The Personalized Health Project (PHP) held a "take action" summit last week with prominent leaders in the life sciences to address gaps occurring between new discoveries in science and their implementation for patients and people. Sponsored by the Ewing Marion Kauffman Foundation, the meeting gathered together about 45 leaders from science, business, investors, government, the media, global health, patient advocacy groups, the wellness movement and "Health 2.0."
Kauffman Foundation to Release a Host of Studies on Health Care Issues in the United States
The Ewing Marion Kauffman Foundation will release several studies over the next month on various aspects of health care. Topics range from a call for a personalized health manifesto to employer-based health insurance effects on business creation and an analysis of the costs and benefits of the health care reform bill’s expanded comparative effectiveness research.
Kauffman Postdoctoral Fellowship Program Will Connect Research, Innovations to Entrepreneurship
Twelve top-tier postdoctoral researchers will have the opportunity to
turn their research and ideas into an entrepreneurial venture. The
Ewing Marion Kauffman Foundation is now accepting applications for its
new Entrepreneur Postdoctoral Fellowship program, which will train
researchers with a penchant for entrepreneurship to commercialize their
innovations into startup businesses.
Large Gender Gap In Patenting Among Life Science Scientists, Kauffman Foundation Sponsored Study Reveals
Male academic scientists in the life sciences secure patents at more than twice the rate of their female colleagues, according to an analysis sponsored by the Ewing Marion Kauffman Foundation.
Moving Innovations to Market
A great deal of promising research consistently fails to be developed and brought to market for practical use, as it could be. This includes basic research in the life sciences that could lead to vital new drugs and medical therapies. It includes research in computing and engineering that could lead to useful new products and job-creating new firms. In short, despite rampant commercialism, what we often have is a failure to commercialize.
Multi-Million Dollar Grant to Advance Medical Innovations in Life Sciences
The Ewing Marion Kauffman Foundation today announced an $8.1 million
grant to the University of Kansas to establish the Institute for
Advancing Medical Innovation, a unique life science proof-of-concept
model that draws support from higher education, philanthropy and
industry experts to move medical innovations from the lab to the market.
Notable Foundations Join Forces to Support Accelerated Drug Development Model
Although research and development dollars in the pharmaceutical industry have doubled over the past 10 years, the number of new drugs reaching the market during that time has remained flat. In support of a new research model that shows early potential to get treatments to market faster and at less cost, today three leading philanthropies jointly announced grants totaling nearly $10.3 million—to the Myelin Repair Foundation (MRF) to not only invest in MRF's unique approach but also to call attention to the demand for a new research paradigm.
Open Innovation: Rx for Improved Human Health
John Wilbanks of Science Common explains how the principles of Open Innovation, that encapsulates
the power of the informed user to drive innovation in new product design, can transform the field of human health.
Pediatric Medical Device Idea Campaign Now Online To Stimulate Early Stage Innovation
The medical device market for children has a higher demand than supply, so the Ewing Marion Kauffman Foundation today announced an eight-week online "idea campaign" to encourage innovations and collaborations to meet the growing medical needs of children.
Personalized Health Manifesto Unveiled at Translational Medicine Alliance Forum in Washington
Despite the promise of a new era of health care in which medicine has shifted from treating conditions to emphasizing prevention fueled by individualized care, a significant gap remains in realizing its benefits because of outmoded attitudes, protocols and procedures targeted for treating mass populations. Such is the core argument and motivation behind the “Personalized Health Manifesto,” released today to kick off the 2010 Translational Medicine Alliance Forum (TMAF) at the Mandarin Oriental.
Reducing Risk through Collaboration Can Generate Increased Economic Returns for Personalized Medicine Sector
As the biopharmaceutical industry faces declining productivity and
innovation, personalized medicine—the concept that a person’s genetic
makeup could be used to tailor medical care to that individual’s
needs—offers promise for increasing economic returns, according to
“Assessing Risk and Return: Personalized Medicine Development & New
Innovation Paradigm.”
Science Commons
Science Commons, an organization that designs strategies and tools for faster, more efficient Web-enabled scientific research, identifies unnecessary barriers to research, crafts policy guidelines and legal agreements to lower those barriers, and develops technology to make research data and materials easier to find and use.
The Importance of Networks
Professor Toby Stuart, recipient of the 2007 Ewing Marion Kauffman Prize Medal for Distinguished Research in Entrepreneurship, discusses his research into how the social and business networks in which would-be entrepreneurs and early-stage firms are immersed influence entrepreneurial processes and outcomes.
The Making of the Personal Health Manifesto
A call for the medical community to support reforms for the rapid adoption of new scientific breakthroughs in personalized health.
The New Role of Academia in Drug Development
A recent town hall meeting offered an opportunity to explore how government, nonprofit organizations, and academic institutions can define new models of working with the private sector to enhance drug development efforts and bring safer, more effective drugs to the market more efficiently.
Translational Medicine Alliance
For medical innovation and treatment breakthroughs to reach patients, several stakeholder groups in the biomedical research and drug development worlds need to collaborate.
Translational Medicine Alliance Forum 2009: Seeding Collaborations that Foster Commercialization
The second annual Translational Medicine Alliance Forum drew interest
from a diverse mix of organizations and leaders interested in moving
medical discoveries from the lab to the market. Founded by the Kauffman Innovation Network and the Translational Medicine Alliance, the 2009 Forum took place May 13-15 in Philadelphia.
Valuing Health Care: Improving Productivity and Quality
Cost trends in U.S. health care consistently increase at about 2.5 percentage points faster than the general rate of inflation – clearly an unsustainable rate. To address what it called "America's most urgent public policy problem," the Ewing Marion Kauffman Foundation released a report that focuses on improving the cost-benefit balance in American health care through open access to medical data.
White Paper on New Models for Accelerated Drug Discovery and Development Is Released
Five leaders in the medical innovation field released a white paper today titled The New Role of Academia in Drug Discovery and Development: New Thinking, New Competencies, New Results. This white paper reflects key recommendations from a July 2010 town hall meeting in Kansas City hosted by Friends of Cancer Research, Kansas Bioscience Authority, The University of Kansas Cancer Center, Ewing Marion Kauffman Foundation and Council for American Medical Innovation.
Winners Announced in 2008 Collegiate Inventors Competition®
The National Inventors Hall of Fame Foundation today announced that a
new method of combating antibiotic-resistant bacteria has won the grand
prize at the 2008 Collegiate Inventors Competition.
